When available, the Online Course format is included with the hard copy, eBook, or audio book formats!
Expiration Date: October 1, 2018
This intermediate-level course offers simplified and practical information relevant to the pharmacological treatment of psychiatric disorders commonly diagnosed in childhood and adolescence. The course discusses the use of psychopharmacology in the treatment of depression, bipolar disorder, anxiety disorders, psychotic disorders, attention deficit/hyperactivity disorder (ADHD), autism spectrum disorders, Tourette’s syndrome, conduct disorders, eating disorders, substance abuse, obsessive-compulsive disorder (OCD), and childhood schizophrenia.
Children and adolescents often differ from adults in presenting symptoms of psychiatric diagnoses as well as in the ways in which drugs are metabolized. Participants will learn about the major biological differences between the brains of children and adolescents and those of adults and about neurobiological mechanisms of various disorders. The course explains how to recognize the key diagnostic signs and symptoms of depression in children and adolescents, and it touches upon concerns about a possible increase in suicides among children and adolescents taking antidepressants.
The course describes the signs of mania that are typical of early-onset bipolar disorder and discusses the functional and structural malfunctions leading to bipolar disorder in children and adolescents. Participants will learn how to select and dose psychotropic medications and how to monitor their effects. The target audience for this course includes healthcare professionals with prescription privileges, as well as social workers, clinical mental health counselors, marriage and family therapists, psychologists, and other professionals whose work includes child and adolescent populations and whose practice requires knowledge of psychotropic medications.
- Social workers participating in this course will receive 6 (clinical) social work CE clock hours. Accreditations
- Psychologists will receive 6 CE credits upon successfully completing this course. APA Approval
- Describe issues that are relevant in the selection of psychotropic medications for children and adolescents.
- Analyze diagnostic, prescriptive, and medication management issues related to children and adolescents with depression.
- Analyze diagnostic indicators, medication management, and treatment guidelines for children and adolescents with bipolar disorder.
- Analyze diagnostic and medication management issues related to children and adolescents with anxiety disorders.
- Analyze diagnostic and medication management issues related to children and adolescents with psychotic disorders.
- Analyze diagnostic and medication management issues related to children and adolescents with attention-deficit/hyperactivity disorder (ADHD).
- Analyze diagnostic and medication management issues related to children and adolescents with autism spectrum disorder.
- Analyze diagnostic and medication management issues related to children and adolescents with sleep disorders, Tourette syndrome, conduct disorder, eating disorders, and substance use disorder.
- Analyze over-the-counter options for the treatment of mental health disorders.
John D. Preston, Psy.D., ABPP, is a professor emeritus at Alliant International University in Sacramento, California, and has also served on the faculty of the University of California, Davis, School of Medicine and the Professional School of Psychology, San Francisco. He has authored twenty-one books in the areas of psychotherapy, neurobiology, and psychopharmacology, and coauthored Clinical Psychopharmacology Made Ridiculously Simple, Consumer’s Guide to Psychiatric Drugs and Handbook of Clinical Psychopharmacology for Therapists. Preston is a fellow of the American Psychological Association and has lectured internationally.
John H. O’Neal, MD is a board-certified psychiatrist in private practice for over twenty-five years and assistant clinical professor in the department of psychiatry at the University of California, Davis, School of Community Hospitals in Sacramento, CA. O’Neal is a Distinguished Fellow of the American Psychiatric Association (APA), and lectures on depression and psychopharmacology to mental health professionals, self-help organizations, and the public. He is coauthor of Handbook of Clinical Psychopharmacology for Therapists.
Mary C. Talaga, RPh, PhD, has been a pharmacist for over thirty years, with specialization in psychiatric pharmacy and pharmacy administration. Talaga has practiced in a variety of clinical settings. She is coauthor of Handbook of Clinical Psychopharmacology for Therapists.
- Courses must be completed on or before the expiration date noted in the course description above.
- You must score 75% or higher on the final exam and complete the course evaluation to pass this course and receive a certificate of completion.
- Through our review processes, Western Schools ensures that this course content is presented in a balanced, unbiased manner and is free from commercial influence. It is Western Schools’ policy not to accept commercial support.
- All persons involved in the planning and development of this course have disclosed no relevant financial relationships or other conflicts of interest related to the course content.